Intrinsic Value of S&P & Nasdaq Contact Us

Minerva Neurosciences, Inc. NERV NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
-19.1%

Stock Statistics — NERV

Minerva Neurosciences, Inc. (NERV) has a market capitalization of $43.22M and trades at $6.18. The 52-week range is 1.15-12.46.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-34.67.

The stock has a beta of -0.21, operates in the Healthcare sector.

Trading Data
Current Price$6.18
52-Week Range1.15-12.46
Volume294.48K
Avg Volume (30D)237.76K
Market Cap$43.22M
Beta (1Y)-0.21
Company
IPO Date2014-07-01
Employees8
CEORemy Luthringer
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS6033802058
CUSIP603380205
Income (Latest Year)
Gross Profit$-5.44K
EBITDA$-15.1M
Operating Income$-15.1M
Net Income$-293.42M
EPS$-34.67
EPS Diluted$-34.67
Shares Outstanding$8.46M
Balance Sheet (Latest Year)
Total Assets$97.97M
Current Assets$83.1M
Cash & ST Investments$82.3M
Total Liabilities$238.72M
Total Debt$64.96M
Net Debt$-17.34M
Total Equity$-140.75M
Debt / Equity-0.46
Valuation Ratios
P/E Ratio-0.2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message